Personalized Cancer Vaccine Market
Updated Date: 20 July 2026   |   Report Code: 6815
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Personalized Cancer Vaccine Market Demand, Size, and Growth Rate Forecast 2035

According to Payal Rabde, who specializes in patient-specific cancer vaccines, mRNA, DNA, and dendritic cell-based, and precision oncology with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the personalized cancer vaccine market. The global personalized cancer vaccine market size was estimated at USD 4.2 billion in 2025 and is predicted to increase from USD 4.99 billion in 2026 to approximately USD 23.32 billion by 2035, expanding at a CAGR of 18.7% from 2026 to 2035. Her analysis highlights the increasing adoption of mRNA vaccine technology, cancer immunotherapy, next-generation sequencing, advanced genomic profiling, increasing clinical trials for personalized cancer vaccines, and innovative biotechnology and vaccine manufacturing technology.  The research also examines the competitive strategies of key industry participants, including Moderna, BiNTech, CureVac, Evaxion Botech, Nykode Therapeutics, Genos Therapeutics, and OSE Immunotherapeutics, shaping the future by advancing precision oncology, integrating artificial intelligence (AI) and next-generation sequencing (NGS), supporting biomarker-driven treatment strategies, promoting precision medicine, and improving long-term cancer management in the global personalized cancer vaccine market.

Last Updated : 20 July 2026 Category: Biotechnology Insight Code: 6815 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Personalized Cancer Vaccine Market Analysis, By Vaccine Type
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By Cancer Type
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By Technology Platform
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By Treatment Approach
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By Distribution Channel
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Personalized Cancer Vaccine Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Cancer Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Technology Platform, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Treatment Approach, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Distribution Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Personalized Cancer Vaccine Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. Personalized Cancer Vaccine Market Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By Vaccine Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By Cancer Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By Technology Platform, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By Treatment Approach, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Personalized Cancer Vaccine Market Analysis, By Distribution Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Vaccine Type
      • By Technology Platform
      • By Treatment Approach
      • By End User
      • By Distribution Channel
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Moderna
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • BioNTech
    • Gritstone Bio
    • CureVac
    • Transgene
    • Evaxion Botech
    • Nouscom
    • Nykode Therapeutics
    • OSE Immunotherapeutics
    • Geneos Therapeutics

FAQ's

Answer : The personalized cancer vaccine market holds a valuation of USD 4.99 billion as of 2026, and will expand to USD 23.32 billion by 2035, achieving a CAGR of 18.7% between 2026 and 2035.

Answer : North America is currently leading the personalized cancer vaccine market by 42% due to the presence of a robust biotech ecosystem.

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar